DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+11.11%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$41.1B
AUM Growth
+$5.37B
(+15%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
6.11%
Top 10 Holdings %
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110
Top Buys
| 1 |
Mastercard
MA
|
+$178M |
| 2 |
Tesla
TSLA
|
+$168M |
| 3 |
NVIDIA
NVDA
|
+$126M |
| 4 |
Nutrien
NTR
|
+$93M |
| 5 |
TSMC
TSM
|
+$90.5M |
Top Sells
| 1 |
Visa
V
|
+$152M |
| 2 |
Northrop Grumman
NOC
|
+$116M |
| 3 |
Honeywell
HON
|
+$95.2M |
| 4 |
Linde
LIN
|
+$92.6M |
| 5 |
Uber
UBER
|
+$71.6M |
Sector Composition
| 1 | Technology | 27.6% |
| 2 | Healthcare | 16.16% |
| 3 | Financials | 10.71% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
SoFi Technologies
SOFI
$30.8B
| $293K | ﹤0.01% |
+19,892
| New | +$293K |
|
1202
RAPT Therapeutics
RAPT
$222M
| $292K | ﹤0.01% |
1,025
+25
| +3% | +$7.12K |
|
1203
Atkore
ATKR
$1.94B
| $291K | ﹤0.01% |
2,569
+763
| +42% | +$86.4K |
|
1204
BWX Technologies
BWXT
$14.7B
| $291K | ﹤0.01% |
6,000
-300
| -5% | -$14.6K |
|
|
RUBY
1205
DELISTED
Rubius Therapeutics, Inc
RUBY
| $289K | ﹤0.01% |
29,000
+800
| +3% | +$7.97K |
|
1206
Aclaris Therapeutics
ACRS
$229M
| $288K | ﹤0.01% |
+20,000
| New | +$288K |
|
1207
Inovio Pharmaceuticals
INO
$145M
| $285K | ﹤0.01% |
4,625
+125
| +3% | +$7.7K |
|
1208
Teva Pharmaceuticals
TEVA
$22.3B
| $284K | ﹤0.01% |
33,683
-121
| -0.4% | -$1.02K |
|
1209
Ryder
R
$7.56B
| $283K | ﹤0.01% |
3,460
+828
| +31% | +$67.7K |
|
1210
Hyatt Hotels
H
$13.8B
| $282K | ﹤0.01% |
2,959
| – | – |
|
1211
Crinetics Pharmaceuticals
CRNX
$3.48B
| $276K | ﹤0.01% |
10,300
+300
| +3% | +$8.04K |
|
1212
Concentrix
CNXC
$3.35B
| $275K | ﹤0.01% |
1,509
+546
| +57% | +$99.5K |
|
1213
Repare Therapeutics
RPTX
$74.3M
| $275K | ﹤0.01% |
13,300
+400
| +3% | +$8.27K |
|
1214
Jefferies Financial Group
JEF
$13.3B
| $270K | ﹤0.01% |
+7,192
| New | +$270K |
|
1215
Edgewise Therapeutics
EWTX
$1.58B
| $269K | ﹤0.01% |
+18,000
| New | +$269K |
|
1216
Tenaya Therapeutics
TNYA
$212M
| $269K | ﹤0.01% |
+14,000
| New | +$269K |
|
1217
Absci
ABSI
$378M
| $268K | ﹤0.01% |
+34,000
| New | +$268K |
|
|
CLR
1218
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $268K | ﹤0.01% |
6,000
-800
| -12% | -$35.7K |
|
|
GTY
1219
Getty Realty Corp
GTY
$1.61B
| $267K | ﹤0.01% |
+8,407
| New | +$267K |
|
1220
Nuvalent
NUVL
$5.63B
| $267K | ﹤0.01% |
+14,000
| New | +$267K |
|
1221
Enanta Pharmaceuticals
ENTA
$190M
| $264K | ﹤0.01% |
3,550
+100
| +3% | +$7.44K |
|
1222
Flowserve
FLS
$7.18B
| $264K | ﹤0.01% |
8,500
| – | – |
|
1223
Akero Therapeutics
AKRO
$3.52B
| $261K | ﹤0.01% |
12,300
+300
| +3% | +$6.37K |
|
1224
MacroGenics
MGNX
$107M
| $261K | ﹤0.01% |
16,600
+400
| +2% | +$6.29K |
|
1225
Arcutis Biotherapeutics
ARQT
$2.13B
| $260K | ﹤0.01% |
12,700
+300
| +2% | +$6.14K |
|